Compounds > 1-methyl-4-phenylpyridinium
Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Brain Inflammation

1-methyl-4-phenylpyridinium has been researched along with Brain Inflammation in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Deng, H; Jia, Y; Ma, Z; Qin, Q1
Gomolin, I; Jeitner, TM; Kalogiannis, M; Krasnikov, BF; Moran, GR; Peltier, MR1
Ambrosio, S; Francisco, R; Giménez-Xavier, P; Gómez-Santos, C1
Cai, DF; Chen, YP; Gao, JP; Li, WW; Sun, S1
Benaïssa, M; Fillebeen, C; Mitchell, V; Pierce, A; Ruchoux, MM; Vincent, S1

Other Studies

5 other study(ies) available for 1-methyl-4-phenylpyridinium and Brain Inflammation

ArticleYear
JWH133 inhibits MPP
    Neuroscience letters, 2020, 02-16, Volume: 720

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Anti-Inflammatory Agents; Astrocytes; Cannabinoids; Cells, Cultured; Encephalitis; Iron; Mesencephalon; Rats; Receptor, Cannabinoid, CB2; Up-Regulation

2020
Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.
    Toxicological sciences : an official journal of the Society of Toxicology, 2016, Volume: 151, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Behavior, Animal; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Encephalitis; Female; Humans; Hypochlorous Acid; Inflammation Mediators; Male; Mice, Inbred C57BL; Mitochondria; Motor Activity; Parkinson Disease, Secondary; Rats, Inbred BN; Rats, Inbred F344; Substantia Nigra; Time Factors; Tumor Necrosis Factor-alpha

2016
Dopamine induces TNFalpha and TNF-R1 expression in SH-SY5Y human neuroblastoma cells.
    Neuroreport, 2007, Oct-29, Volume: 18, Issue:16

    Topics: 1-Methyl-4-phenylpyridinium; Antibodies; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Encephalitis; Humans; Neuroblastoma; Neurons; Neurotoxins; Oxidopamine; Parkinson Disease; Receptors, Tumor Necrosis Factor, Type I; Substantia Nigra; Tumor Necrosis Factor-alpha; Up-Regulation

2007
Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.
    Neuroscience bulletin, 2008, Volume: 24, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Biomarkers; CD11b Antigen; Cell Count; Cell Survival; Disability Evaluation; Diterpenes; Dopamine; Encephalitis; Epoxy Compounds; Gliosis; Herbicides; Immunosuppression Therapy; Immunosuppressive Agents; Male; Microglia; Neurons; Parkinsonian Disorders; Phenanthrenes; Rats; Rats, Sprague-Dawley; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase

2008
Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment.
    Brain research. Molecular brain research, 2001, Nov-30, Volume: 96, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; Aged; Antineoplastic Agents; Cell Line, Transformed; Encephalitis; Female; Gene Expression; Humans; Lactoferrin; Male; Microglia; Oxidative Stress; Parkinsonian Disorders; Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Tumor Necrosis Factor-alpha

2001